Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

Fig. 2

Improvements in asthma control and lung function in the OP. (A) Change in the proportion of patients with an ACT score ≥ 20 from baseline to 1 year of follow-up. (B) Proportion of patients who achieved increases in pre-BD FEV1 over a certain threshold after 1 year of follow-up. ACT, asthma control test; BD, bronchodilator; FEV1, forced expiratory volume in 1 s

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us